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ABSTRACT
Introduction: Beverage consumption is a modifiable risk factor for type 2 diabetes (T2D), but there is insufficient
evidence to inform the suitability of substituting 1 type of beverage for another.
Objective: The aim of this study was to estimate the risk of T2D when consumption of sugar-sweetened beverages
(SSBs) was replaced with consumption of fruit juice, milk, coffee, or tea.
Methods: In the European Prospective Investigation into Cancer and Nutrition (EPIC)–InterAct case–cohort study of 8
European countries (n = 27,662, with 12,333 cases of incident T2D, 1992–2007), beverage consumption was estimated at
baseline by dietary questionnaires. Using Prentice-weighted Cox regression adjusting for other beverages and potential
confounders, we estimated associations of substituting 1 type of beverage for another on incident T2D.
Copyright C© American Society for Nutrition 2019. All rights reserved. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is
properly cited.
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Results: Mean ± SD of estimated consumption of SSB was 55 ± 105 g/d. Means ± SDs for the other beverages were as
follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d; coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Substituting coffee for
SSBs by 250 g/d was associated with a 21% lower incidence of T2D (95% CI: 12%, 29%). The rate difference was −12.0
(95% CI: −20.0, −5.0) per 10,000 person-years among adults consuming SSBs ≥250 g/d (absolute rate = 48.3/10,000).
Substituting tea for SSBs was estimated to lower T2D incidence by 22% (95% CI: 15%, 28%) or −11.0 (95% CI: −20.0,
−2.6) per 10,000 person-years, whereas substituting fruit juice or milk was estimated not to alter T2D risk significantly.
Conclusions: These findings indicate a potential benefit of substituting coffee or tea for SSBs for the primary prevention
of T2D and may help formulate public health recommendations on beverage consumption in different populations.
J Nutr 2019;149:1985–1993.
Keywords: diabetes, epidemiology, dietary guidelines, beverages, sugar-sweetened beverages
Introduction
Beverage consumption is one of the modifiable risk factors for
noncommunicable diseases, including type 2 diabetes (T2D)
(1–4). Observational studies have indicated a benefit or harm
of different types of beverages for the primary prevention of
noncommunicable diseases. For instance, adults consuming ≥1
daily serving of sugar-sweetened beverages (SSBs) are likely
to experience a 13% greater incidence of T2D (5), whereas
adults consuming 2–3 daily servings of coffee or tea are
likely to experience a 15–25% lower incidence of T2D (6–8).
This evidence has been supported by analyses that evaluated
associations of different types of beverages with incident
T2D separately. Evidence remains limited, however, on the
potential benefit of substituting 1 type of beverage for another
by examining different types of beverages simultaneously
(9).
Effects of substituting alternative beverages for SSBs are
of particular interest to inform clinical and public health
recommendations. This is because consumption of SSBs has
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been related to cardiometabolic burden worldwide (2–4) and
because multiple alternatives of beverages to SSBs are available,
with diversity in sales and consumption across countries (10,
11). The effects on cardiometabolic risks have been tested
in trials that, for example, examined the effect of replacing
SSBs with milk, fruit juice, water, or noncaloric artificially-
sweetened beverages (ASBs) on cardiometabolic risk factors
(12–14). Clinical endpoints have been studied only in a few
cohorts for stroke (15) or T2D (9, 16–18) in the United
States and the United Kingdom (15–17). We aimed to provide
further evidence by evaluating participants in the European
Prospective Investigation into Cancer and Nutrition (EPIC)–
InterAct consortium (19), a case–cohort study of T2D that
reported associations of selected beverages with T2D, including
tea (20), milk (21), fruit juice (22), ASBs (22), and SSBs
(22), but had not yet evaluated coffee, milk beverages, or
water. Accounting for the available evidence (4–8, 19–24), we
hypothesized that substituting tea or coffee for SSBs could lower
risk of T2D, whereas substituting the other beverages for SSBs
would not affect the risk.
Methods
Study population
EPIC-InterAct is a prospective case–cohort study nested within the EPIC
study cohort from 8 European countries (France, Italy, Spain, the United
Kingdom, the Netherlands, Germany, Sweden, and Denmark) (19).
From a total of 340,234 cohort participants (3.99 million person-years
of follow-up) with stored blood and reported diabetes status, EPIC-
InterAct identified 16,835 adults randomly selected (subcohort) and
ascertained 12,403 incident cases of T2D occurring by 31 December,
2007; the identified cases included 778 cases in the subcohort (19,
25). In the current study, we excluded adults with prevalent diabetes
(n = 548) or without information on T2D (n = 129) or baseline diet
(n = 117). After these exclusions, 27,662 adults were evaluated in our
analysis (n cases = 12,333) (Supplemental Figure 1). All participants
gave written informed consent. The study was approved by local ethics
of the article and from the same link in the online table of contents at https:
//academic.oup.com/jn/.
NGF and NJW contributed equally to this work.
Address correspondence to FI (e-mail: fumiaki.imamura@mrc-epid.cam.ac.uk).
Abbreviations used: ASB, artificially-sweetened beverage; EPIC, European
Prospective Investigation into Cancer and Nutrition; HbA1c, glycated
hemoglobin; hsCRP, high-sensitivity C-reactive protein; RD, rate difference;
SSB, sugar-sweetened beverage; T2D, type 2 diabetes.
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committees and the Internal Review Board of the International Agency
of Research on Cancer.
Ascertainment of T2D
A diagnosis of incident T2D was defined as self-report of physician’s
diagnosis verified by at least 1 independent source, including multiple
information sources reviewed by each participating center (19): self-
report, linkage to primary-care registers, secondary-care registers,
medication use (drug registers), hospital admissions, and mortality
data (Supplemental Table 1). Information from any follow-up visit or
external evidence with a date later than the baseline visit was used.
In Denmark and Sweden, incident cases were identified via local and
national diabetes and pharmaceutical registers and were considered to
be verified. Follow-up was to the date of diagnosis, 31 December, 2007,
or the date of death, whichever occurred first.
Beverage consumption
In EPIC, dietary consumption was assessed by a dietary FFQ or
diet history harmonized across EPIC cohorts (26–29). Five beverages
were used as the primary exposures: SSBs (carbonated/soft drinks
or diluted syrups, and sweetened milk beverages), fruit juice (fruit
or vegetable juices, and fruit concentrates), milk, coffee (caffeinated
or decaffeinated), and tea (Supplemental Table 2 for classification).
We included sweetened milk beverages (e.g., milkshakes) as SSBs,
not as milk, because of their presumably high sugar contents and
their significant positive association with T2D incidence, similar to
SSB consumption, in the EPIC-Norfolk study using 7-d food records
(18). Based on published reviews and previous EPIC-InterAct analyses,
we combined decaffeinated coffee with coffee (8) and vegetable juice
with fruit juice (22). Reported consumption of each beverage had
moderate correlations—adjusted for age, sex, and energy intake—with
corresponding measures of 24-h recalls on average across countries
(n = 2347): r = 0.33 for SSB, r = 0.38 for fruit juice, r = 0.52 for
milk, r = 0.60 for coffee, and r = 0.52 for tea.
We separately evaluated ASBs (available among 82.8% of partic-
ipants), decaffeinated coffee (72.1%), vegetable juice (57.0%), and
water (58.4%) (Supplemental Table 1). Possible alternative groupings
(e.g., classifying sweetened milk beverages as milk rather than SSBs)
were evaluated additionally. These beverages were evaluated in the
secondary analyses because the missing information (not at random)
could limit validity of estimating absolute incidence and because these
beverages were assumed to be irregularly consumed and thus the
validity of self-reported consumption of these beverages was considered
unclear. Alcohol, evaluated previously in EPIC-InterAct (24), was used
as a covariate because alcoholic beverages cannot be considered as an
alternative to the other beverages in practice.
Other study variables
At baseline, weight, height, and waist circumference were measured
directly in every center, except waist circumference was not assessed
in Oxford, UK, and Umea, Sweden (19). Sociodemographic factors,
smoking status, physical activity, menopausal status and use of hormone
replacement therapy (women only), use of medication, and prevalent
diseases were self-reported (19, 30). Food groups were derived from
dietary questionnaires or history (28) and considered as dietary
confounders. Total energy intake was estimated from European food
composition tables and centrally analyzed for EPIC (28). As an indicator
of under-, normal, or overreporting of individuals’ diet, we calculated
a ratio of total energy intake to total energy requirement as previously
performed in EPIC-Spain (31) and categorized the ratio into the 3 levels
by 1.0 ± 2 × within-individual SD of the ratio (31).
Serum triglycerides, HDL cholesterol, high-sensitivity C-reactive
protein (hsCRP), and hemoglobin A1c (HbA1c) were measured at
Stichting Ingenhousz Laboratory using serum samples stored at −196◦C
(or −150◦C in Denmark), with exception of Umeå, where plasma
samples were used (details in Supplemental Methods). These markers
were additionally examined as potential mediators for associations of
beverage consumption with incident T2D.
Statistical analysis
All analyses were performed using Stata version 14.0 software (Stata).
Outlying values of beverage consumption were Winsorized (replaced
with each mean +3 × SD, country-specific) to reduce their influence.
The prospective association between consumption of each type of
beverage (SSBs, fruit juice, milk, coffee, and tea) and incident T2D
was evaluated using Prentice-weighted Cox regression for every country
separately, with age as the underlying timescale, providing estimates of
HRs and 95% CIs (32). HR per 250 g/d of each beverage was estimated
to evaluate the same quantity of each beverage; sensitivity analyses
assigned different amounts to different beverages [e.g., 150 g/d for tea
(33)] accounting for varying portion sizes per serving. Country-specific
estimates were then pooled across countries by multivariable random-
effects meta-analysis (34). Models were adjusted for different types
of beverages mutually and for potential confounders: research center,
sex, education level, occupation, marital status, menopausal status and
use of hormone replacement therapy (only for women), family history
of diabetes, prevalent clinical conditions (hypertension, dyslipidemia,
cardiovascular diseases, and cancer), and the aforementioned quality
indicator of dietary reporting (31). We also adjusted for lifestyle
factors: smoking status, physical activity level, dietary supplement use,
alcohol consumption, and dietary consumption (total energy intake,
vegetables, fruits, nuts, cheese, yogurt, red meats, processed meats, fish,
confectionary, and cereals). We further adjusted for BMI (in kg/m2) and
waist circumference because obesity status may have altered beverage
consumption (22). We additionally tested nonlinearity of an association
between each of the beverages and incident T2D by meta-regression
with restricted cubic spline.
We estimated rate differences (RDs) in T2D incidence comparing
different amounts of beverage servings (e.g., between 250 and 0 g/d),
using parameter estimates from Cox regression models. RD for each
beverage was estimated based on the absolute incidence rate of T2D
of adults consuming ≥250 g/d of each beverage. In the main analysis,
difference in 10-y rates was modeled using a weighted average of
the cumulative incidence of T2D in each country-specific subcohort,
weighted for sampling probability (35). Differences during 5 and 20 y of
follow-up were also estimated. CIs were estimated using bootstrapping
(1000 iterations).
We estimated the potential effects of substituting 250 g/d of 1 type
of beverage for the same quantity of another type of beverage (16). The
substitution effect was estimated as the difference in effect measures
(e.g., βcoffee – βSSB for the association of substituting coffee for SSB), as
previously conducted (15–17). This modeling produces, for example, an
estimated change in T2D incidence if an individual decreased SSB and
then increased coffee consumption, whereby the interpretation makes
an assumption of causality for 2 exposure variables. As the secondary
analysis, we also modeled substitution between 2 beverages by an
average amount of each beverage in each country, not assuming serving
sizes of beverages.
Sensitivity analyses were performed to examine the impact of
various assumptions on the results. We estimated HRs for substitution
between 250 g/d of SSBs and 150 g/d of 1 of the other beverages,
considering possibly different amounts/serving across beverages; for
beverage variables without Winsorization; and for beverages with log-
transformation. Multiple imputation (20 data sets) was performed to
investigate the impact of missing covariate data (36); the main results
were from a single imputation in which between-imputation variability
was considered small (0.3% of total variability). We assessed influences
of reverse causation by censoring T2D cases diagnosed within the first
6 y (approximately the midpoint of follow-up time in EPIC-InterAct).
We also examined the influence of errors in dietary measurements
(21, 37). Using dietary estimates from single 24-h recalls in a subset
(n = 2347) as a reference for dietary questionnaire or history data, we
conducted multivariable calibration for HRs for different beverages by
computing
βcalibrated = βnoncalibrated ×
(∑
total
−
∑
error
)−1∑
total
(1)
Beverage consumption and incident type 2 diabetes 1987
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TABLE 1 Baseline characteristics of study participants in the EPIC-InterAct case–cohort study1
Subcohort2 (n = 16,103) Cases of diabetes (n = 12,333)
Age, y 52 ± 9.0 56 ± 7.7
Women, % 62 50
Education ≥high school, % 21 13
Currently employed, % 51 45
Current smokers, % 26 28
Physical activity, ≥moderately active, % 43 37
Postmenopausal,3 % 51 34
Hormone therapy,3 % 15 14
Family history of diabetes,4 % 23 38
Prevalent conditions, %
Hypertension 19 38
Dyslipidemia 18 36
Cardiovascular disease 3.0 7.0
Dietary supplement use, % 39 39
Dietary consumption
Energy, MJ/d 9.0 ± 2.8 9.1 ± 3.1
Alcohol,5 servings/d 1.3 ± 2.0 1.5 ± 2.5
Fiber, g/d 23 ± 8.0 23 ± 8.4
Vegetables, g/d 184 ± 120 180 ± 126
Fruits, g/d 235 ± 191 229 ± 201
Processed meat, g/d 37 ± 33 42 ± 39
Yogurt, g/d 63 ± 88 59 ± 91
Confectionery, g/d 25 ± 51 29 ± 69
Ratio of energy intake to energy requirement 0.92 ± 0.30 0.90 ± 0.30
Underreporters of dietary consumption, % 11.0 14.0
BMI, kg/m2 26 ± 4 30 ± 5
Waist circumference, cm 86 ± 13 97 ± 13
Hemoglobin A1c, mmol/mol 36 ± 4.8 43 ± 10
Triglycerides, mmol/L 1.4 ± 0.9 2.0 ± 1.3
HDL cholesterol, mmol/L 1.5 ± 0.4 1.2 ± 0.4
C-reactive protein, mg/L 2.2 ± 3.9 3.8 ± 5.2
1For continuous and categorical variables, respectively, means ± SDs and percentages are presented. A case–cohort design was
undertaken in which the subcohort and incident cases of type 2 diabetes were independently sampled from the eligible participants
in the EPIC cohort. By design, 774 incident cases were also in the subcohort. EPIC, European Prospective Investigation into Cancer
and Nutrition.
2Definitions of each type, percentage of nonconsumers and of those consuming >250 g/d, and characteristics by beverage
consumption are presented in Supplemental Tables 2 and 3.
3Calculated among women.
4Not available in 2 research centers and thus evaluated among 8850 adults in the subcohort and 6752 cases.
5Consumption levels in total alcoholic beverages were calculated in each cohort. One serving was defined as 150 mL.
where β is a vector of regression coefficients, log(HRs), and
∑
is the
total and error variance–covariance matrices of beverage consumption
estimates (37).
We tested if the estimated substitution effects were consistent across
country, baseline age, sex, smoking, BMI, and the measure of under- or
overreporting of dietary data. Heterogeneity by country was assessed
by I2. For the other variables, we performed stratified analyses
followed by meta-regression testing between-strata heterogeneity. We
also examined if associations of interest were mediated by triglycerides,
HDL cholesterol, hsCRP, and HbA1c by including these variables in the
model adjusting for potential confounders.
Results
Participants’ characteristics at baseline are presented in Table 1.
Mean ± SD consumption of SSBs was 55 ± 105 g/d in
the subcohort. Means ± SDs for the other beverages were
as follows: fruit juice, 59 ± 101 g/d; milk, 209 ± 203 g/d;
coffee, 381 ± 372 g/d; and tea, 152 ± 282 g/d. Different
types of beverage consumption were not correlated or weakly
correlated mutually (r = −0.02 to −0.23) (data not shown).
Socioeconomic and lifestyle factors and prevalent comorbidity
showed complex associations with beverage consumption
(Supplemental Table 3). For example, longer education history
was significantly related to higher consumption of fruit juice,
coffee, or tea, but lower consumption of SSBs and milk
(P < 0.007 for each). Higher consumption of fruit juice
was related to lower use of dietary supplements and greater
prevalence of hypertension, dyslipidemia, and cardiovascular
diseases (P < 0.001 for each). Underreporting of dietary
intakes was more prevalent among consumers of tea (12%)
or coffee (10%) than among consumers of other beverages
(<10%).
Positive associations with incidence of T2D were seen
for SSBs and for milk, whereas inverse or null associations
were seen for coffee, tea, and fruit juice (Table 2). HRs of
SSBs indicated 44% higher T2D incidence (95% CI: 28%,
62%) per 250 g/d increment with adjustment for demographic
characteristics only. The association was attenuated but still
significant after adjustment for socioeconomic and lifestyle
1988 Imamura et al.
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TABLE 2 Prospective associations between habitual consumption of beverages and incidence of type 2 diabetes in 8 countries in
the EPIC-InterAct case–cohort study (n = 27,662)1
Sugar-sweetened beverages Fruit juice Milk Coffee Tea
HR (95% CI) per 250 g/d2
Adjusted for demographic variables3 1.44 (1.28, 1.62) 0.99 (0.91, 1.07) 1.06 (0.96, 1.17) 0.97 (0.93, 1.01) 0.90 (0.88, 0.93)
+ The other potential confounders 1.25 (1.14, 1.37) 0.98 (0.91, 1.05) 1.10 (1.02, 1.18) 0.92 (0.89, 0.95) 0.90 (0.86, 0.95)
+ BMI, waist circumference 1.18 (1.08, 1.28) 1.06 (0.96, 1.17) 1.10 (1.02, 1.19) 0.91 (0.89, 0.94) 0.93 (0.87, 0.98)
Rate difference (95% CI) comparing 250 g/d with 0 serving/d4
Adjusted for demographic variables3 +13 (+8.7, +17) − 3.2 (−7.2, +0.9) +1.0 (−0.9, +2.9) − 2.0 (−3.5, −0.5) − 4.8 (−7.8, −1.9)
+ The other potential confounders +8.9 (+2.1, +16) − 0.5 (−6.1, +5.0) +3.5 (+0.7, +6.2) − 3.3 (−5.8, −0.8) − 3.6 (−6.9, −0.3)
+ BMI, waist circumference +7.4 (−1.6, +16) +1.1 (−5.6, +7.8) +4.3 (+0.8, +7.7) − 4.0 (−7.6, −0.4) − 3.1 (−7.6, +1.5)
1EPIC, European Prospective Investigation into Cancer and Nutrition.
212,333 cases were evaluated. From the InterAct subcohort, 774 cases/192,287 person-years contributed. Five beverages were evaluated simultaneously using country-specific
Prentice-weighted Cox proportional hazard regression models. Country-specific estimates were pooled by multivariable random-effects meta-analysis.
3Five beverages were adjusted mutually for each other. Demographic covariates included recruitment centers, age, and sex. Further adjustment for potential confounders included
education, marital status, hormone replacement therapy, menopausal status, history of oral contraceptive use, hypertension, dyslipidemia, family history of diabetes, prevalent
diseases (coronary heart disease and stroke), smoking, physical activity, alcohol consumption, dietary supplement use, and dietary consumption (total energy intake, vegetables,
fruits, nuts, cheese, yogurt, red meats, processed meats, fish, confectionary, and cereals).
4Per 1000 persons × 10 y (on average, 39.5/10,000 person-years; 95% CI: 36.8, 42.5).
covariates and for adiposity measures. In the most adjusted
model, milk consumption was weakly but positively associated
with T2D incidence, whereas coffee consumption and tea
consumption were inversely associated. Fruit juice was not
significantly associated. There was no significant evidence of
departure from linearity (Supplemental Figure 2).
In sensitivity analyses, the findings for SSBs, coffee, and tea
were similar to results from the main analyses, whereas findings
for milk and fruit juice were different (Supplemental Tables 4
and 5). Milk consumption was not associated with T2D, after
excluding under- or overreporters based on estimated energy
intake and energy requirement, calibrating for measurement
error, or censoring events in the first 6 y. After accounting
for measurement error, fruit juice consumption was positively
associated with T2D. In analyses assessing whether or not
physiological markers mediated an observed association, the
findings for milk and tea were attenuated toward the null,
potentially mediated by the physiological markers, whereas
findings for SSBs and coffee remained significant without
marked changes.
Modeling comparative associations of beverage consump-
tion with T2D, substituting coffee or tea for SSBs was estimated
to lower T2D incidence significantly (Figure 1, Table 3).
In analyses adjusted for potential confounders and adiposity
measures, substituting coffee for SSBs by 250 g/d was estimated
to lower the incidence of T2D by 21% (95% CI: 12%, 29%) or
lower cases by 12.0 (95% CI: 5.0, 20.0) per 10,000 person-years
of adults consuming SSBs ≥250 g/d. Similarly, substituting tea
for SSBs was estimated to lower T2D incidence by 22% (95%
CI: 15%, 28%) or T2D events by 11.0 (95% CI: 2.6, 20.0) per
10,000 person-years. When considering 5- and 20-y follow-up
instead of 10 y, RDs were halved and doubled, respectively, as
would be expected (Supplemental Table 6). The other estimates
of substitution effects were not significant: as exception, the
substitution of coffee or tea for milk was significantly associated
with lower incidence (Table 3).
In analyses examining subtypes of beverages among subsets,
consumption of sweetened milk beverages (separated from
SSBs) was positively associated with incident T2D with an
HR of 2.56 (95% CI: 1.04, 6.29) per 250 g/d (Supplemental
Table 7). Other subgroups of beverages (decaffeinated coffee,
vegetable juice, ASBs, and water) were not significantly
associated with incident T2D. The HR for vegetable juice
was not estimated precisely (95% CI: >10). Substituting
decaffeinated coffee, ASBs, or water for SSBs was estimated to
lower T2D incidence by 23% (95% CI: 15%, 30%), 22% (95%
CI: 17%, 26%), or 13% (95% CI: −1.0%, 24%), respectively.
Heterogeneity by country was moderate to substantial overall.
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FIGURE 1 Prospective associations of substituting alternative
beverages for SSBs with incidence of type 2 diabetes in the
EPIC–InterAct case–cohort study. Cumulative incidence curves are
displayed for adults consuming >250 g/d of SSB and adults
modeled to replace SSB with 1 alternative beverage (milk, fruit
juice, coffee, or tea) by 250 g/d: those for coffee and tea were
almost identical. Baseline hazards of the subcohort and regression
estimates (Table 3) derived from multivariable-adjusted Prentice-
weighted Cox regression including the 5 variables simultaneously,
demographic factors (recruitment centers, age, and sex), education,
marital status, hormone replacement therapy, menopausal status,
history of oral contraceptive use, hypertension, dyslipidemia, family
history of diabetes, prevalent diseases (coronary heart disease or
stroke), BMI, waist circumference, smoking, physical activity, alcohol
consumption, dietary supplement use, and dietary consumption (total
energy intake, vegetables, fruits, nuts, cheese, yogurt, red meats,
processed meats, fish, confectionary, and cereals). ∗P < 0.001. EPIC,
European Prospective Investigation into Cancer and Nutrition; SSB,
sugar-sweetened beverage.
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TABLE 3 Prospective associations of beverage consumption with incident type 2 diabetes, modeled to estimate incidence rates if
participants substituted 1 beverage for the other: EPIC-InterAct case–cohort study (n = 27,662)1
Incidence per
10,000
person-years2
Alternative beverages substituted for the beverage in the row (by 250 g/d)
Beverage estimated to be substituted for
an alternative beverage (per 250 g/d)
Sugar-sweetened
beverages Fruit juice Milk Coffee Tea
HR (95% CI)3
Sugar-sweetened beverages 39.5 1.00 (reference) 0.89 (0.74, 1.07) 0.91 (0.82, 1.02) 0.79 (0.72, 0.88) 0.78 (0.72, 0.85)
Fruit juice 1.00 (reference) 1.03 (0.9, 1.18) 0.89 (0.83, 0.95) 0.89 (0.76, 1.05)
Milk 1.00 (reference) 0.85 (0.78, 0.92) 0.82 (0.74, 0.91)
Coffee 1.00 (reference) 1.02 (0.94, 1.11)
Tea 1.00 (reference)
Rate differences (95% CI) per 10,000
person-years in adults with ≥250 g/d for
each beverage4
Sugar-sweetened beverages 48.3 0.0 (reference) − 5.8 (−16.0, 4.4) − 2.0 (−8.5, 4.4) − 12.0 (−20.0, −5.0) − 11.0 (−20.0, −2.6)
Fruit juice 25.2 4.1 (−3.9, 12.0) 0.0 (reference) 2.2 (−2.8, 7.2) − 3.4 (−8.2, 1.4) − 2.8 (−7.9, 2.4)
Milk 41.3 3.6 (−5.2, 12.0) − 2.8 (−10.0, 4.4) 0.0 (reference) − 8.2 (−13, −3.7) − 7.3 (−13.0, −1.4)
Coffee 38.4 12.0 (2.5, 21.0) 5.4 (−2.2, 13.0) 8.2 (3.7, 13.0) 0.0 (reference) 0.9 (−4.6, 6.5)
Tea 28.5 11.0 (0.6, 21.0) 4.5 (−4.0, 13.0) 7.3 (1.4, 13.0) − 0.9 (−6.5, 4.6) 0.0 (reference)
112,333 cases were evaluated, along with the subcohort of the total (774 cases/192,287 person-years). Prentice-weighted Cox proportional hazard regression was modeled for
each country. Country-specific estimates were pooled by multivariable random-effects meta-analysis. EPIC, European Prospective Investigation into Cancer and Nutrition.
2Calculated from the subcohort.
3In each model, all beverages were mutually adjusted for each other. Demographic covariates included recruitment centers, age, and sex. Further adjustment for potential
confounders included education, marital status, hormone replacement therapy, menopausal status, history of oral contraceptive use, hypertension, dyslipidemia, family history
of diabetes, prevalent diseases (coronary heart disease and stroke), BMI, waist circumference, smoking, physical activity, alcohol consumption, dietary supplement use, and
dietary consumption (total energy intake, vegetables, fruits, nuts, cheese, yogurt, red meats, processed meats, fish, confectionary, and cereals).
4Analysis was performed by estimating incidence rate of adults consuming ≥250 g/d of the beverage of each row and by estimating rate differences representing effects of
replacing the beverage of each row with the beverage of each column. The second column presents crude rates per 10,000 person-years of adults consuming ≥250 g/d of each
beverage.
For example, I2 varied from 39.7% for tea to 77.3% for
replacing SSBs with another type of beverage (Supplemental
Figure 3). The heterogeneity was not explained by average age,
proportion of men or women, average BMI, or absolute inci-
dence (P > 0.05 in meta-regression). Of prespecified variables,
sex was identified to be a significant effect modifier for fruit
juice (P-interaction = 0.02; P > 0.2 for others; Supplemental
Figure 3). In men, but not in women, substituting fruit juice for
SSBs was estimated to reduce T2D risk (HR: 0.69; 95% CI:
0.53, 0.90). This association in men and the heterogeneity by
sex were not significant (P > 0.2 for each) in a post hoc analysis
censoring events during the first 6 y of follow-up.
Discussion
Substituting consumption of coffee or tea for consumption
of SSBs was associated with an ∼20% lower incidence of
T2D across 8 European populations. In secondary analyses,
substitution of decaffeinated coffee or ASBs for SSBs was also
associated with lower incidence of T2D. By contrast, fruit
juice and milk appeared unlikely to be suitable alternatives
to SSBs for the prevention of T2D. Our study suggests the
potential benefits of alternative beverages to SSBs for the
primary prevention of T2D.
Our analysis provides the first evidence for populations
of multiple European countries that coffee consumption
was inversely associated with T2D incidence, whereas the
association has been well established in individual countries
across global regions (7); consumption of water or vegetable
juice was not significantly associated with T2D incidence; and
consumption of sweetened milk beverages was significantly
positively associated with T2D incidence. Potential effects of
substituting 1 beverage for another on T2D have been examined
in only a few studies in the United States or the United
Kingdom (16–18). We were unable to distinguish between
sweetened and unsweetened tea or coffee, whereas EPIC-
Norfolk evaluated detailed 7-d dietary records and highlighted
positive associations of sweetened coffee or tea with T2D risk
(18). Available evidence from this study and others indicates
that T2D risk may be reduced by substituting unsweetened
coffee or tea for SSBs but not by using fruit juice or milk as
the replacement beverages.
Our secondary analysis of substituting ASBs for SSBs
by 1 serving/d in the subset produced a stronger estimate
(Supplemental Table 7) than that from the Nurses’ Health Study
(HR: 0.95; 95% CI: 0.90, 0.98) (16) or the EPIC-Norfolk study
(its study population partly overlapped with the population in
EPIC-InterAct) (HR: 0.95; 95% CI: 0.80, 1.08) (17, 18). The
heterogeneity between these results may have reflected different
degrees of population-specific residual confounding (38, 39) or
the use of different dietary assessment methods. Accounting
for the heterogeneity and the uncertainty of potential adverse
effects of ASBs on appetite, gut microbiota, and metabolic risks
(38), evidence remains weak for the benefit of substituting ASBs
for SSBs for T2D prevention. In modeling substitution of water
for SSBs, the potential reduction in T2D incidence appeared
quantitatively similar to those in EPIC-Norfolk (HR: 0.86; 95%
CI: 0.74, 0.99) (no overlapping population with EPIC-InterAct)
(18) and the Nurses’ Health Study (HR: 0.93; 95% CI: 0.89,
0.97) (16). Despite the consistency, results on consumption of
water, as well as ASBs, should be interpreted cautiously partly
because of residual confounding due to health consciousness.
Based on our findings and other evidence, further research
using controlled clinical studies and population-based studies is
needed to better understand the efficacy of consumption of ASBs
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and water (or hydration) on the development of T2D (4, 40).
Although this is beyond the scope of our study, ASBs and water
may serve as favored alternatives (4, 40, 41) to SSBs because
ASBs and water have low or zero energy content, and SSBs,
ASBs, and water share a similar context of consumption as cold
beverages. Effectiveness is likely to be related to such practical
considerations, and relevant behaviors remain to be studied as
well.
Our study indicated that milk consumption was positively
associated with T2D but not after accounting for under-
or overreporters of dietary consumption, measurement error,
or reverse causation. These findings and prior nonsignificant
findings in meta-analyses of low-fat or high-fat milk and T2D
(23) indicate that milk is unlikely to be a healthy alternative to
SSBs for the prevention of T2D. Clinical trials have suggested
a benefit of milk consumption through its insulinogenic and
antioxidative properties (42) with diversity in comparators (e.g.,
water or other beverages) and types of milk (e.g., full-fat or
skim). Sweetened milk beverages have been little studied but
are likely to be harmful based on biological plausibility related
to added sugars (18) and this study using FFQs and the EPIC-
Norfolk study using 7-d food records (18). In summary, specific
types of milk remain to be evaluated, but consumption of
milk or milk beverages is unlikely to contribute to the primary
prevention of T2D.
Policy implications from this work deserve discussion. Our
findings indicate the possible benefit of explicitly recommending
alternatives to SSBs. This corroborates with the principle of
beverage guidelines proposed in 2006 for the US population (4).
The importance of such guidelines has been further supported
by our estimates of T2D risk differences in the order of 10s per
10,000 person-years. This indicates that a benefit for individuals
may be too small, but a population-level benefit could be
meaningful, particularly in countries in which prevalence of
T2D is alarming (43) and millions of adults are consuming
SSBs [e.g., 50% of adults in the United States (5) and up
to two-thirds in European countries (10)]. Our findings for
consumption of milk and sweetened milk beverages also provide
an implication for dietary guidelines. Dairy consumption has
been widely recommended in federal dietary guidelines as a
source of calcium, vitamin D, and other nutrients, and this
recommendation has been questioned (44). By contrast, our
finding does not support a presumed benefit, whereas sweetened
milk is likely to be harmful at least in the context of the
primary prevention of T2D. Further clinical, modeling, and
policy research are warranted to explore the utility of explicitly
recommending substitution of specific beverages for SSBs in
diverse populations.
Despite no direct evidence, our work should stimulate
further research on the effectiveness and efficacy of substituting
alternative beverages for SSBs. For individuals who are at high
risk of T2D and consume SSBs habitually, advice to consume
other beverages instead of SSBs is reasonable to consider, rather
than advice to reduce SSBs solely. Its benefit has been indicated
in a trial demonstrating improvement of a diet by substituting
ASBs or water for SSBs (45). Reducing SSB consumption may
be easier to achieve than modifying food consumption because
SSBs are often consumed in isolation rather than in combination
after being cooked, for instance, with other foods. To strengthen
these considerations with empirical evidence, behavioral effects
of promoting consumption of healthy alternatives to SSBs
should be established in future intervention studies.
EPIC-InterAct had the strengths of longitudinal design; a
large number of T2D cases adjudicated in a standardized
manner (19); the availability of covariates; 24-h recall dietary
data in the subset; and a wide variety of beverage types,
including water and milk beverages for which little evidence was
available to date. A number of limitations of this study typical
of observational research exist and limit a causal inference for a
dietary effect on disease incidence. Thus, the substitution effects
should be considered as estimates modeled from observational
evidence. Relevant limitations include residual confounding due
to unmeasured or imprecisely measured confounders. Although
our calibration for measurement errors indicated robustness
of our main conclusion, measurement errors were likely to
exist heterogeneously across countries in estimating absolute
amounts of beverage consumption and in estimating habitual
consumption because dietary exposures were measured only at
baseline. Bias during the follow-up could occur; for example,
an increase in SSB consumption over years (10, 11) could have
widened between-individual variance of SSB consumption and
made HRs per 1 serving/d overestimated. Misclassification is
also possible because InterAct (and many previous studies) had
no data on sports drinks, sweetened coffee or tea, and other
subtypes, although these subtypes of beverages may increase the
risk of T2D (3, 4, 18, 46). Availability of data was limited on
preparation methods for beverages; for instance, populations in
Italy and the United Kingdom prepare (brew) coffee differently,
which may have differential biological effects and contribute to
heterogeneity in prospective associations. Last, generalizability
is limited because we primarily studied white adults in Europe
(7, 8). Because tea, coffee, SSBs, ASBs, and water are consumed
globally (2, 3) in diverse cultural and culinary settings, future
work is warranted to characterize healthy alternatives to SSBs
in different regions of the world.
In conclusion, across 8 European countries, SSB consump-
tion was positively associated, and consumption of coffee or tea
was inversely associated, with the risk of developing T2D. In our
modeling of substitution effects of different beverages, ∼20%
of risk was estimated to be reduced by substituting coffee or
tea for SSBs. This work provides implications for the primary
prevention of T2D by reducing SSB consumption and increasing
consumption of healthier beverage options.
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